A Quality Improvement Intervention to Decrease Postoperative Opioid Prescriptions in Pediatric Oncology Patients. Issue 4 (May 2020)

• Record Type: Journal Article
• Authors: Mansfield, Sara A.; El Gohary, Yousef; Kimble, Amy; Wynn, Lynn; Hall, Elizabeth A.; Anghelescu, Doralina L.; Davidoff, Andrew M.; Murphy, Andrew J.
• Is Part Of: Journal of pediatric hematology/oncology. Volume 42:Issue 4(2020)
• Publication Date: 2020-05
• Subjects: pediatric oncology -- opioid -- surgery; Pediatric hematology -- Periodicals; Tumors in children -- Periodicals; 618.9215
• DOI: 10.1097/MPH.0000000000001641
• Languages: English
• ISSNs: 1077-4114

Abstract

Abstract : Purpose: This quality improvement initiative aimed to minimize opioid prescribing after oncologic pediatric surgery. Methods: Retrospective surgical data collected at a pediatric cancer hospital from July 2016 to June 2018 included hospitalization details, oral morphine equivalents prescribed, unplanned visits/calls because of pain, and parental/patient satisfaction with pain control. The quality improvement initiative promoted opioid prescription at discharge on the basis of prior inpatient requirements and education regarding nonopioid analgesia. Upon commencing this project in July 2018, we collected data prospectively. Results: The retrospective and the prospective cohorts included 271 and 99 patients, respectively. Mean (SD) oral morphine equivalents (mg/kg) prescribed upon discharge was significantly reduced in the prospective (0.75±1.34) versus retrospective cohorts (5.48±6.94, P <0.001). The unplanned visits/calls regarding pain were 23 (retrospective, 8.5%) and 2 (prospective, 2.0%). In total, 44 patients (44.4%) received an opioid prescription at discharge in the prospective cohort, significantly fewer than retrospective cohort (251, 92.6%, P <0.001), and used a mean of 34.3 of 159.8 (21.5%) doses dispensed. Length of stay was comparable ( P =0.88) between cohorts. Prospective satisfaction rate was 96.2%, leaving 3 patients (3.8%) not satisfied with their pain control regimen. Conclusions: Dramatic reduction of opioid prescriptions after oncologic surgery can be achieved without detriment to patient satisfaction or readmissions. Level of Evidence: Level V.